Clinical Trial Details
EORTC-40101
Back to Clinical Trials Database
An open-label, randomized phase III trial of cisplatin and 5-fluorouracil with or without panitumumab for patients with nonresectable, advanced or metastatic esophageal squamous cell cancer (ESCC)
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 28-Feb-2012 Date Step1 close: 27-May-2015 |
| Data management at EORTC | No |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 13 - All Groups: 146 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/ |
| NCT number | |
| EudraCT | 2010-020606-15 |
